Cristina Oliva

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden.

Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.

Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud.

Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark.

Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.

RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark

MetaCure (USA), Inc. engages in the development and commercialization of invasive treatment for diabetes. The company was founded by Shlomo Ben-Haim in 2003 and is headquartered in Orangeburg, NY.

REMA 1000 AS retails grocery products and offers a chain of supermarket. Its office tasks include joint marketing and procurement, finance and information technology, operations, establishing, and central support. The regional offices provides regional marketing and establishes new stores in the area. The company was founded in 1979 and is headquartered in Oslo, Norway.

Part of Biocoat, Inc., Chempilots A/S is a Danish company that specializes in developing and providing custom polymers using state-of-the-art technology. The company is based in Farum, Denmark. The company offers a range of pre-specified products to signify their capabilities and give customers a starting point for selection. Chempilots specializes in poly(ortho esters) (poe), which belong to a class of degradable polymeric materials and were initially developed for drug delivery applications. Chempilots was acquired by Biocoat, Inc. on July 11, 2023.

Trialbee AB provides software solutions and services to the pharmaceutical industry. It operates as a software company which specializes in clinical trial planning and management solutions. The firm offers global pharmaceutical companies and web-based solution for patient recruitment to clinical trials. The company was founded by Carl Johan Tobias Folkesson and Per Jonas Billing in October 2010 and is headquartered in Malmo, Sweden.

AirHelp Ltd. develops mobile applications to claim compensation for delayed or cancelled flights. Its proprietary system tracks cancelled overbooked or delayed flights and automatically informs and helps customers about compensation rights. The firm provides assistance with the application for compensation and with possible proceedings. The company was founded by Greg Roodt, Nicolas Branas Michaelsen, Henrik Zillmer and Morten Lund in 2013 and is headquartered in Ely, The United Kingdom.

Part of Shionogi & Co., Ltd., Shionogi Ltd. is a British company that manufactures and distributes pharmaceutical products. The company is based in London, UK.

Xynteo AS is a Norwegian strategic advisory company that operates with a driven approach. The company is based in Oslo, Norway.

RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway.

Part of BerGenBio ASA, BerGenBio Ltd. is a British clinical-stage biopharmaceutical company founded in 2017. The company is based in Oxford, UK. The company develops innovative drugs for aggressive diseases, including cancer and severe respiratory infections.

Nordic Eye Invest ApS (Nordic Eye) is an independent Danish venture capital firm which was founded in 2016. Nordic Eye is fully-owned by its partners, and has offices in Copenhagen, Denmark, and Los Angeles, California.

Part of Nordic Eye Invest ApS, Nordic Eye Management ApS is an international venture capital firm based in Copenhagen, Denmark. The Danish company's brand promise is to spot, add, and exit, creating high value through a unique network, energetic and passionate collaboration, and an imaginative and commercial mindset. Nordic Eye has a strong personal network throughout the world, especially in the core markets. The CEO of the company is Martin Olin.

Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation.

The Russell Group of Universities is an organization that represents 24 leading universities. The organization is based in the United Kingdom. The group is dedicated to maintaining excellent research, providing an exceptional teaching and learning experience, and fostering strong connections with businesses and the public sector.

Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York.